Difference between revisions of "Dimethyltryptamine (DMT)"
| Line 1: | Line 1: | ||
| − | Dimethyltryptamine is a hallucinogenic drug<ref>Philip Boyd, [http://www.bmj.com/cgi/reprint/4/5839/540.pdf Emotional Problems in Childhood and Adolescence: Adolescents Drug Abuse and Addiction], British Medical Journal, 1972, 4, 540-543</ref>. | + | Dimethyltryptamine is a hallucinogenic drug<ref>Philip Boyd, [http://www.bmj.com/cgi/reprint/4/5839/540.pdf Emotional Problems in Childhood and Adolescence: Adolescents Drug Abuse and Addiction], British Medical Journal, 1972, 4, 540-543</ref>. The drug is alleged to create a Euphoria linked to feelings of "‘transcendence’, ‘ineffability’ and ‘grace’ that often appear in descriptions of ayahuasca sessions by physically and psychologically healthy individuals. Many reported experiences are similar to descriptions of samadhi in advaitan Hinduism, satori in Zen Buddhism or beatific vision in Christianity"<ref>Robert S. Gable, (2007) [http://web.cgu.edu/faculty/gabler/Ayahuasca%20paper%20PDF.pdf Risk assessment of ritual use of oral |
| + | dimethyltryptamine (DMT) and harmala alkaloids], Addiction, 102, 24–34</ref>. | ||
==Resources== | ==Resources== | ||
Latest revision as of 18:17, 28 January 2010
Dimethyltryptamine is a hallucinogenic drug[1]. The drug is alleged to create a Euphoria linked to feelings of "‘transcendence’, ‘ineffability’ and ‘grace’ that often appear in descriptions of ayahuasca sessions by physically and psychologically healthy individuals. Many reported experiences are similar to descriptions of samadhi in advaitan Hinduism, satori in Zen Buddhism or beatific vision in Christianity"[2].
Resources
Philip Boyd, Emotional Problems in Childhood and Adolescence: Adolescents Drug Abuse and Addiction, British Medical Journal, 1972, 4, 540-543
Notes
- ↑ Philip Boyd, Emotional Problems in Childhood and Adolescence: Adolescents Drug Abuse and Addiction, British Medical Journal, 1972, 4, 540-543
- ↑ Robert S. Gable, (2007) [http://web.cgu.edu/faculty/gabler/Ayahuasca%20paper%20PDF.pdf Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids], Addiction, 102, 24–34
